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GENETIC DIVERSITY OF PATHOGENIC MICROORGANISMS AND ITS MEDICAL AND PUBLIC HEALTH SIGNIFICANCE *JS Virdi, P Gulati, M Pai
In the last decade or so, significant amounts of data have of genetic diversity data has been the development of been generated on genetic diversity of a number of pathogens. diagnostics, therapeutics and vaccines. Poorly understood This has been accomplished largely due to the development diversity of a pathogen can lead to development of of genotyping techniques such as multilocus enzyme diagnostics that cannot detect the entire set of pathogen electrophoresis, restriction fragment length polymorphism, genotypes causing a particular disease. For example, the random amplified polymorphic DNA, pulse field gel discovery of highly divergent strains of human electrophoresis, repetitive sequence-based polymerase chain immunodeficiency virus (HIV) that were not reliably detected reaction, multilocus sequence typing and DNA sequencing. by a number of commonly used diagnostic kits emphasized Why is the study of genetic diversity important and what can the need for studies to type HIV variants. Another example is it contribute to medicine and public health? Several the development of new tests for the detection of tuberculosis observations of both fundamental and applied nature have infection. Comparative genomics has allowed the identification been gleaned from studies on diversity. Thanks to these of genomic segments (e.g., region of difference (RD1)) that studies, we now understand that although pathogenic are present in Mycobacterium tuberculosis but deleted from microbes constitute a small proportion of all microbial species, Mycobacterium bovis BCG sub-strains. Antigens encoded by many are characterized by high genetic diversity. For example such regions (e.g., ESAT-6) are currently being used in novel, organisms such as the HIV and influenza virus mutate blood-based interferon-gamma assays and these assays have extensively and pose major challenges to disease control. been shown to be more specific than the tuberculin skin test. Further, such studies have dispelled the notion of clonal nature Also, to develop more effective therapeutics and vaccines, it of pathogens. We now realize that population structures of is imperative that the candidate drugs/vaccines are evaluated pathogenic microbes range from effectively panmictic to strictly against a set of carefully selected genotypes, which are clonal.
1 Therefore, a better understanding of genetic diversity representative of the pathogen population.
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of pathogenic microorganisms may allow us to devise public development for influenza is a classic illustration. health interventions that may be more effective.
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In addition to the medical and public health implications, The field of molecular epidemiology has greatly capitalized the long-term benefits which may accrue from the study of on the knowledge gained from genetic diversity of pathogens. pathogen diversity include understanding of the evolution and The core of molecular epidemiology is genotyping of strains. emergence of new pathogens, pathogenicity per se and This has been particularly useful in studying global phylogenetics. 5 As the oldest inhabitants of the earth, epidemiology of pathogens and their transmission dynamics. microbes have a highly chequered history of evolution. The long-term spread of the pathogens over large Comparative genomics of pathogens associated with human, geographical areas encompassing continents have been animal and plant hosts may reveal insights into how tracked because we have databases of their genetic pathogens evolved. Our recent understanding of the fingerprints. Genetic diversity studies have been useful in emergence of human pathogens like Yersinia pestis from Y.
Vaccine identifying the sources of outbreaks. Such studies have also helped resolve unequivocally whether the recurrence of an infectious disease is due to relapse caused by the same strain or re-infection of the host by a new strain.
In addition to molecular epidemiology, a major application pseudotuberculosis has been possible only with the study of large number of genetic variants of these pathogens. 6 However, genetic diversity studies have been constrained by certain problems. Among these, problems associated with adequate sample selection are paramount. An appropriate sample of the pathogen population is a prerequisite for genetic diversity studies. Presently most studies rely on isolates of a pathogen obtained from culture collection (e.g., referral) centers. Such centers, however, may not represent actual diversity extant in nature, as majority of the strains in such collections are obtained from clinical settings and thus, biased towards the highly pathogenic strains with the exclusion of the opportunistic and accidental pathogenic forms. This www.ijmm.org ) .
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Virdi et al -Genetic Diversity of Microorganisms problem must be overcome by undertaking structured sampling schemes. 7 Another concern is the lack of foolproof genotyping methods that are highly accurate in distinguishing between strains. The development of the multilocus sequence typing (MLST) method in recent years has raised hopes in this regard. 8 The sequence data obtained using MLST is reproducible and highly portable among laboratories, allowing development of global databases easily available on the internet so that global comparisons can be made. Lack of a good framework for interpretation of genetic diversity data is another stumbling block in our understanding of pathogen diversity. There is a need for standardized, international
